Salvatore Calabrese

2021

In 2021, Salvatore Calabrese earned a total compensation of $345.4K as Chief Financial Officer at Gain Therapeutics, a 8% increase compared to previous year.

Compensation breakdown

Bonus$40,000
Non-Equity Incentive Plan$37,389
Salary$268,000
Total$345,389

Calabrese received $268K in salary, accounting for 78% of the total pay in 2021.

Calabrese also received $40K in bonus and $37.4K in non-equity incentive plan.

Rankings

In 2021, Salvatore Calabrese's compensation ranked 11,431st out of 12,415 executives tracked by ExecPay. In other words, Calabrese earned more than 7.9% of executives.

ClassificationRankingPercentile
All
11,431
out of 12,415
8th
Division
Manufacturing
5,036
out of 5,505
9th
Major group
Chemicals And Allied Products
2,234
out of 2,375
6th
Industry group
Drugs
1,984
out of 2,096
5th
Industry
Pharmaceutical Preparations
1,467
out of 1,546
5th
Source: SEC filing on May 13, 2022.

Calabrese's colleagues

We found two more compensation records of executives who worked with Salvatore Calabrese at Gain Therapeutics in 2021.

2021

Matthias Alder

Gain Therapeutics

Chief Operating Officer

2021

Eric Richman

Gain Therapeutics

Chief Executive Officer

News

You may also like